Vitamin C and the Immune System: What the Science Actually Proves

Linus Pauling won two Nobel Prizes. He also spent the last decades of his life convinced that vitamin C megadoses could cure cancer and the common cold, and wrote books promoting 10,000–18,000mg per day. His passion for vitamin C shaped popular belief in ways that decades of subsequent research have failed to fully correct.

The truth about vitamin C and immune function is simultaneously more evidence-based and more nuanced than either the megadose enthusiasts or the dismissive sceptics admit. Understanding where the evidence is strong, where it is weak, and where bioavailability fundamentally limits what oral supplementation can achieve is essential.

---

What Vitamin C Actually Does

Vitamin C (ascorbic acid) is a water-soluble antioxidant and enzyme cofactor with multiple physiological functions relevant to immune defence:

Direct immune functions: - Stimulates neutrophil production and function — neutrophils are the first-responder immune cells that engulf and destroy pathogens; vitamin C accumulates inside neutrophils at concentrations 50–100x higher than plasma, protecting them from oxidative damage during phagocytosis - Enhances T-cell proliferation and differentiation - Supports antibody production (IgG and IgM) - Antiviral activity — inhibits viral replication through multiple mechanisms (interferon induction, direct inactivation of certain viruses) - Maintains epithelial barrier function — the physical first line of immune defence

Antioxidant and structural functions: - Required for collagen synthesis — the hydroxylation of proline and lysine in collagen precursors requires vitamin C as cofactor; without it, connective tissue, wound healing, and vessel integrity are compromised - Recycles other antioxidants — regenerates vitamin E and glutathione from their oxidised forms - Adrenal cortex — among the highest vitamin C concentrations in the body; required for cortisol synthesis; depleted by physical and psychological stress

---

The Cochrane Review: What It Actually Found

The landmark 2013 Cochrane review by Hemilä and Chalker — "Vitamin C for preventing and treating the common cold" — reviewed 29 trials involving over 11,000 participants. This is the most quoted study in vitamin C discussions, and almost always misrepresented.

What it found:

1. Regular supplementation at 200mg+/day did NOT significantly reduce the incidence of the common cold in the general population

2. However, regular supplementation DID reduce cold duration by approximately 8% in adults and 14% in children — modest but real

3. In high-physical-stress populations (marathon runners, soldiers in subarctic conditions, skiers), regular vitamin C supplementation reduced cold incidence by approximately 50% — a substantial and significant effect

4. Therapeutic high-dose supplementation started at onset of illness showed inconsistent results — some positive, some negative

The practical interpretation: - Vitamin C is not a cold preventer for average people - It may modestly reduce duration of colds when supplemented regularly - It has significant preventive benefits in people under extreme physical stress - Starting vitamin C when a cold starts has weaker evidence than regular prophylactic use

---

The Oral Bioavailability Ceiling

This is the most important limitation of vitamin C supplementation that marketing never mentions.

Vitamin C absorption is tightly controlled by intestinal sodium-dependent vitamin C transporters (SVCTs). These transporters saturate as dose increases, meaning the percentage of vitamin C absorbed falls dramatically with higher doses:

| Oral Dose | Approximate Absorption Rate | Amount Absorbed | |---|---|---| | 200mg | ~70–90% | ~140–180mg | | 500mg | ~50–70% | ~250–350mg | | 1,000mg | ~30–50% | ~300–500mg | | 2,000mg | ~20–30% | ~400–600mg | | 4,000mg | ~10–20% | ~400–800mg |

The ceiling for plasma vitamin C saturation via oral supplementation is approximately 70–80 µmol/L — achievable at doses around 400–500mg/day. Above this dose, additional oral vitamin C is excreted in urine rather than raising plasma levels further.

Taking 5,000mg of vitamin C orally does not produce meaningfully higher blood levels than 500mg. The megadose enthusiasm is based on a fundamental misunderstanding of pharmacokinetics.

The exception: intravenous (IV) vitamin C

IV vitamin C bypasses intestinal absorption limits entirely, achieving plasma concentrations 30–70x higher than oral dosing can produce. At these pharmacological concentrations (>1,000 µmol/L), vitamin C exhibits pro-oxidant activity — selectively generating hydrogen peroxide in cancer cells and tissues with high catalytic iron, while normal cells are protected by catalase.

This is the basis of IV vitamin C in cancer adjunct therapy (studied but not proven). It requires IV administration — oral dosing cannot replicate it.

---

Liposomal Vitamin C: Marketing vs Evidence

Liposomal vitamin C is a premium product in which vitamin C is encapsulated in lipid vesicles (liposomes) — the claim being that the lipid encapsulation protects vitamin C from intestinal breakdown and enhances absorption.

What the evidence shows: - A 2016 study (Davis et al.) found liposomal vitamin C achieved slightly higher circulating levels vs unencapsulated ascorbic acid at the same dose - However, the same study found liposomal vitamin C did not achieve the extreme plasma concentrations of IV administration - The bioavailability advantage is real but modest — perhaps 10–20% better absorption at the same oral dose

Conclusion: Liposomal vitamin C is better than standard oral supplements but not transformative. At 1,000mg, the difference between standard and liposomal in terms of absorbed dose is modest. The significant price premium may not be justified for most people.

---

Buffered vs Standard Ascorbic Acid

Standard ascorbic acid is mildly acidic (pH ~2.5) and can cause GI irritation, particularly heartburn and reflux, in sensitive individuals at higher doses.

Buffered vitamin C (calcium ascorbate, sodium ascorbate, magnesium ascorbate) has higher pH (around 6-7) and is significantly better tolerated. Calcium ascorbate also provides a small amount of calcium.

Ester-C: A patented form containing calcium ascorbate with metabolites (threonate, lyxonate) — marketed as superior; evidence for meaningful bioavailability advantage is limited.

For those with GI sensitivity at doses above 500mg, buffered ascorbate is the practical solution.

---

Vitamin C and Adrenal Function

The adrenal cortex has the second-highest vitamin C concentration of any tissue in the body (after the anterior pituitary). During physiological stress — infection, surgery, critical illness, exercise, psychological stress — adrenal vitamin C is released into circulation and rapidly depleted.

This is one of the most underappreciated aspects of vitamin C nutrition: stress increases vitamin C requirements above normal dietary intake. The increase in infections following stressful life events may partly reflect stress-induced adrenal vitamin C depletion impairing immune function.

Studies in critically ill patients show plasma vitamin C drops to near-zero within hours of ICU admission. Vitamin C infusion in critical illness (particularly sepsis) has shown mortality benefits in some studies (CITRIS-ALI, VITAMINS trials) though results are mixed.

For the generally healthy: ensuring adequate vitamin C intake during high-stress periods is a reasonable practical intervention.

---

Collagen and Skin Ageing

One of the less disputed roles of vitamin C is its essentiality for collagen production. Every collagen molecule requires vitamin C-dependent hydroxylation of proline and lysine residues — without it, collagen fibrils cannot cross-link correctly.

Scurvy (severe vitamin C deficiency) is characterised by connective tissue breakdown, skin fragility, poor wound healing, and bleeding gums — all consequences of failed collagen synthesis.

At sub-scorbutic deficiency levels (insufficient for optimal function but not causing clinical scurvy): - Wound healing is impaired - Skin quality and elasticity may be reduced - Gum health is compromised

Oral vitamin C supplementation in people with sub-optimal intake improves skin collagen density and elasticity in studies, with effects visible at 12–16 weeks.

---

Vitamin C and Cancer: The Evidence Landscape

The story of vitamin C and cancer is complicated by the oral/IV distinction:

Oral vitamin C and cancer prevention: Higher dietary vitamin C intake is associated with lower cancer rates in epidemiological studies, but confounding is extensive (high-vitamin-C diets are also high in other protective compounds).

High-dose oral vitamin C during chemotherapy: A study by Yeom et al. (2007) found oral vitamin C improved quality of life in terminal cancer patients. Evidence for survival benefit via oral supplementation is weak.

IV vitamin C as adjunct cancer therapy: Multiple phase I/II trials show IV vitamin C (75–100g infusions) combined with standard chemotherapy is safe and may enhance efficacy in some cancers. A 2019 phase II RCT in glioblastoma showed improved survival with IV vitamin C + standard therapy. Not yet standard-of-care, but a legitimate research area.

The oral/IV distinction is the whole story here — the pharmacological concentrations needed for anticancer activity cannot be achieved orally.

---

Upper Limits and Dosing

Tolerable Upper Intake Level (UL): - EU: 2,000mg/day - UK/NHS guidance aligns broadly with this

At doses above 1,000–2,000mg/day: - GI effects dominate: diarrhoea, loose stools, cramping (the "bowel tolerance" threshold varies individually) - Theoretical risk of oxalate stone formation in those predisposed (vitamin C is metabolised to oxalate) — relevant for those with kidney stone history

Practical dosing guidance:

| Purpose | Dose | Form | |---|---|---| | General maintenance / immune support | 200–500mg/day | Ascorbic acid | | High-stress / illness periods | 500–1,000mg/day | Buffered or liposomal | | GI-sensitive individuals | 500mg buffered (calcium ascorbate) | Buffered ascorbate | | Collagen/skin focus | 500–1,000mg/day | With bioflavonoids | | Athletic recovery | 200–500mg/day (avoid megadoses — may blunt adaptation) | Standard ascorbic acid |

Important note for athletes: High-dose antioxidant supplementation (including vitamin C at >500mg/day) may blunt the adaptive hormetic response to exercise-induced oxidative stress. Evidence is mixed but sufficient to advise against chronic megadosing around training sessions.

---

The Bottom Line

Vitamin C is a genuinely important immune-support nutrient — but not in the megadose mythology Pauling promoted. The evidence supports 200–500mg/day for modest reduction in cold duration, significant reduction in cold incidence during high-stress periods, collagen support, and adrenal function. The oral bioavailability ceiling at around 500mg means doses above this add little to plasma levels. Take it buffered for GI tolerance, take it consistently rather than therapeutically, and do not expect it to prevent colds or cure cancer in the doses achievable orally.